Concepedia

Effect of evolocumab on saphenous vein graft patency after coronary artery bypass surgery (NEWTON-CABG CardioLink-5): an international, randomised, double-blind, placebo-controlled trial

Subodh Verma, Lawrence A. Leiter, Hwee Teoh, G.B. John Mancini, Adrian Quan, Randi Elituv, Meena Verma, Elizabeth Misner, Michael Szarek, Kevin E. Thorpe,

The Lancet · 2025 · 20 citations · 16 references

DOI

Concepts

References

16

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Gregory G. Schwartz, Philippe Gabríel Steg, Michael Szarek et al. · New England Journal of Medicine · 2018 · 3.5K citations · Full text

, , +17

The Effect of Aggressive Lowering of Low-Density Lipoprotein Cholesterol Levels and Low-Dose Anticoagulation on Obstructive Changes in Saphenous-Vein Coronary-Artery Bypass Grafts

New England Journal of Medicine · 1997 · 970 citations · Full text

, , +17

Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction

Stephen J. Nicholls, Yu Kataoka, Steven E. Nissen et al. · JACC. Cardiovascular imaging · 2022 · 429 citations

, , +16

Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease

Michelle L. O’Donoghue, Robert P. Giugliano, Stephen D. Wiviott et al. · Circulation · 2022 · 380 citations · Full text

, , +17

Long-Term Effects on Clinical Outcomes of Aggressive Lowering of Low-Density Lipoprotein Cholesterol Levels and Low-Dose Anticoagulation in the Post Coronary Artery Bypass Graft Trial

Genell L. Knatterud, Yves Rosenberg, Lucien Campeau et al. · Circulation · 2000 · 274 citations

, , +17